Status:
COMPLETED
Dermatological Evaluation of Topic Compatibility - Dermacyd Breeze
Lead Sponsor:
Sanofi
Conditions:
Healthy
Eligibility:
FEMALE
18-60 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to demonstrate the absence of irritation potential (primary dermal irritability and cumulated dermal irritability) and allergy (sensibilization) of the product Dermacyd Po...
Eligibility Criteria
Inclusion
- Phototype Skin I,II, III e IV
- Integral skin test in the region
Exclusion
- Use of Antiinflammatory and/or immunosuppression drugs
- Personnel history of atopy
- History of sensitivity or irritation for topic products
- Active cutaneous disease
- Use of new drugs or cosmetics during the study
- The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
Key Trial Info
Start Date :
December 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT00668577
Start Date
December 1 2007
Last Update
February 10 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sanofi-aventis administrative office
São Paulo, São Paulo, Brazil